Actos Bladder Cancer Lawsuits Expected to Top 10,000
Visitors to www.SideEffectActos.com can read up on the link between Actos and bladder cancer, get the latest updates on the Actos litigation and fill out a free confidential form to schedule a consultation with one of the firm’s experienced Actos attorneys. The California-based firm is currently investigating claims from patients in all 50 states who allege that taking Actos caused them to develop bladder cancer and other serious side effects.
Takeda Pharmaceuticals, the Japanese manufacturer of Actos, currently faces approximately 3,500 injury lawsuits from patients who say they’ve been harmed by Actos. The Type 2 diabetes drug has been the focus of an ongoing safety investigation by the U.S. Food and Drug Administration since September 2010. In June 2011, the FDA issued a new warning advising Actos users that remaining on the drug longer than a year could significantly increase the risk of developing bladder cancer.
Health officials in France and Germany have already issued a recall of the drug based on the potential for serious side effects. Despite this limited recall, the European Medical Agency continues to support the use of Actos for diabetes patients when other treatment methods have proven insufficient.
A recall in the U.S. could be a serious blow to Takeda, who reported nearly $4 billion in earnings last year in Actos sales. The FDA recently made the decision to delay review of a new Type 2 diabetes drug manufactured by the company which combines Actos with another drug, algoliptin. As of yet, Takeda has yet to issue any statement about the pending Actos lawsuits.
If you or someone you love has developed bladder cancer after using Actos, the law firm of Nadrich & Cohen, LLP urges you to contact their Injury Hotline at 1-800-722-0765. The firm is currently offering free initial case evaluations for Actos users who believe they may have a claim after being injured by the drug. If you’ve used Actos but have not yet experienced any serious side effects, you may visit www.SideEffectActos.com for the latest news, updates and information about the pending litigation. Don’t hesitate to call today to speak with one of the firm’s experienced Actos injury attorneys.
National Client Intake Coordinator
Nadrich & Cohen, LLP
12100 Wilshire Blvd. Suite 1250
Los Angeles, CA 90025
Nadrich & Cohen, LLP is a national law firm specializing in handling claims from clients who've been injured by defective medical devices, harmful prescription drugs, car accidents, motorcycle accidents, bicycle accidents and dog bites.
12100 Wilshire Blvd.
Los Angeles, CA 90025
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actos Bladder Cancer Lawsuits Expected to Top 10,000 here
News-ID: 202939 • Views: 1712
More Releases from Nadrich & Cohen, LLP
Johnson & Johnson Defends Withdrawal of PMA for Rejected Hips
Nadrich & Cohen, LLP reports that Johnson & Johnson is defending its withdrawal of a PMA for a rejected metal hip device that was reportedly sold overseas. Los Angeles, CA, February 16, 2012 – The Johnson & Johnson Company is facing more criticism after a recent New York Times article revealed that the company continued to market a metal hip resurfacing system overseas, despite the fact that the FDA failed to
Actos Bladder Cancer Lawsuits Continue to Mount as Attorneys Push for Consolidat …
With new Actos bladder cancer lawsuits being filed every day, the plaintiffs and their attorneys are urging for the consolidation of these cases. Some 3500 Actos lawsuits have been filed in state and federal courts across the country, including Illinois, New York, New Jersey, Ohio and California. The law firm of Nadrich & Cohen LLP is currently investigating claims from Actos users in all 50 states who claim they developed
New Actos Bladder Cancer Resource Center Offers Answers to Concerned Patients
Los Angeles, CA, December 6, 2011 -- Nadrich & Cohen LLP, a prominent national law firm, has established a new website geared towards helping Actos users who developed bladder cancer after taking the drug. Visitors to the new site, www.SideEffectActos.com, can find the latest updates, news and information on the Actos bladder cancer litigation. The link between Actos and bladder cancer first came to light in September 2010, when the
New Vaginal Mesh Safety Recommendations Issued
National law firm Nadrich & Cohen LLP is endorsing new recommendations issued by the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUGS) regarding the use of transvaginal mesh to treat pelvic organ prolapse in certain women. In a joint statement, the two organizations called for physicians to limit their use of vaginal mesh only to high-risk women for whom other treatment methods would not be
More Releases for Actos
Nadrich & Cohen LLP Clarifies Statements Regarding Actos Bladder Cancer Lawsuits
Los Angeles, CA, January 24, 2012 – National law firm Nadrich & Cohen LLP would like to clarify previous statements regarding the pending Actos bladder cancer litigation. Earlier press releases included incorrect information regarding the total number of Actos lawsuits filed against the drug’s manufacturer, Takeda Pharmaceuticals. Those releases, based on media reports, estimated the number of lawsuits filed in state and federal courts nationwide in connection with Actos numbered
Federal Panel Votes to Consolidate Actos Bladder Cancer Lawsuits
Nadrich & Cohen LLP reports that a federal judicial panel has voted to consolidate pending Actos bladder cancer claims into a multidistrict litigation for pretrial proceedings. Los Angeles, CA, January 5, 2012 – Plaintiffs in the Actos bladder cancer litigation have successfully moved to have the federal lawsuits consolidated into a multidistrict litigation for pretrial proceedings. The cases will be transferred to the Western District Court of Louisiana, with the
More Actos Bladder Cancer Lawsuits Filed in Los Angeles
Nadrich & Cohen LLP reports that new lawsuits have been filed in Los Angeles against the maker of Actos by two patients who allege the drug caused bladder cancer. Los Angeles, CA, December 30, 2011 – As Takeda Pharmaceuticals continues to battle litigation over its Type 2 diabetes drug Actos, three additional lawsuits were filed in a Los Angeles court. The newest claims join the thousands of other Actos lawsuits that
Nadrich & Cohen Now Reviewing Actos Bladder Cancer Claims
Los Angeles, CA, December 12, 2011 – Nadrich & Cohen LLP, a prominent national law firm, is now reviewing claims from Actos users in all 50 states who developed bladder cancer after taking the drug. In an effort to connect with even more Actos users across the country, the firm has established an online resource center at www.SideEffectActos.com. Actos was approved by the U.S. Food and Drug Administration to treat adults
FDA Delays Actos Combo Drug Review as Actos Bladder Cancer Lawsuits Continue to …
Los Angeles, CA, December 9, 2011 – As Actos bladder cancer lawsuits continue to mount, the Food and Drug Administration has opted to delay its review of a new Type 2 diabetes drug that combines Actos with algoliptin. The FDA’s decision represents another blow to Japanese drug-maker Takeda Pharmaceuticals, who may face as many 10,000 lawsuits from Actos users who claim they developed bladder cancer after taking the drug. The
Actos Bladder Cancer Link Has More Patients Seeking Legal Help
Los Angeles, CA, November 28, 2011 – As more Actos users are discovering the link between the Type 2 diabetes drug and bladder cancer, the need for experienced legal representation has increased. Prominent national law firm Nadrich & Cohen, LLP is now offering free initial case evaluations for Actos users who’ve experienced serious side effects, including bladder cancer. The U.S. Food and Drug Administration issued the first warnings about possible